---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-270490"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2025-11-07T23:59:59+00:00"
generated_at: "2026-05-16T23:06:42.832095+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Benitec Biopharma prices $100M equity offering at $13.50/share (7.4M shares total)

## Summary
- Underwritten public offering of 5,930,000 shares plus 889,500-share underwriter option; concurrent registered direct offering of 1,481,481 shares to Suvretta Capital affiliates.
- Gross proceeds ~$100M; net proceeds to fund product candidate programs, working capital, and general corporate purposes.
- Offerings priced at $13.50 per share; expected to close Nov 7, 2025 subject to customary conditions.
- Company, execs, directors, and Suvretta Capital subject to 90-day lock-up on share sales after Nov 5, 2025.

## SEC filing metadata
- accession: 0001193125-25-270490
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2025-11-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312525270490/0001193125-25-270490-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312525270490/d53447d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-270490
- JSON: https://secwatch.observer/filing/0001193125-25-270490.json
- Plain text: https://secwatch.observer/filing/0001193125-25-270490.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.